ATE546543T1 - Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase - Google Patents
Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretaseInfo
- Publication number
- ATE546543T1 ATE546543T1 AT08765357T AT08765357T ATE546543T1 AT E546543 T1 ATE546543 T1 AT E546543T1 AT 08765357 T AT08765357 T AT 08765357T AT 08765357 T AT08765357 T AT 08765357T AT E546543 T1 ATE546543 T1 AT E546543T1
- Authority
- AT
- Austria
- Prior art keywords
- epha4
- secretase
- screening method
- new substrate
- gamma secretase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94268707P | 2007-06-08 | 2007-06-08 | |
| PCT/JP2008/060567 WO2008150010A1 (ja) | 2007-06-08 | 2008-06-09 | γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE546543T1 true ATE546543T1 (de) | 2012-03-15 |
Family
ID=40093812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08765357T ATE546543T1 (de) | 2007-06-08 | 2008-06-09 | Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7910324B2 (de) |
| EP (1) | EP2166110B1 (de) |
| JP (1) | JP5511377B2 (de) |
| AT (1) | ATE546543T1 (de) |
| WO (1) | WO2008150010A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008150010A1 (ja) | 2007-06-08 | 2008-12-11 | Eisai R & D Management Co., Ltd. | γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法 |
| EP2177623A4 (de) * | 2007-07-19 | 2010-12-29 | Eisai R&D Man Co Ltd | SCREENINGVERFAHREN MIT c-MET, EINEM NEUEN SUBSTRAT FÜR GAMMA-SEKRETASE |
| EP2192181A4 (de) * | 2007-08-01 | 2010-12-08 | Eisai R&D Man Co Ltd | Screening-verfahren mit nutzung des neuen substrats c-ret für gamma-sekretase |
| JP5580598B2 (ja) | 2007-11-15 | 2014-08-27 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | γ−セクレターゼの新規基質ＥｐｈＡ７を利用したスクリーニング方法 |
| EP2223999B1 (de) | 2007-11-30 | 2017-10-18 | Eisai R&D Management Co., Ltd. | Epha4-polypeptid mit neuartiger aktivität und verwendung davon |
| WO2010141974A1 (en) * | 2009-06-10 | 2010-12-16 | The University Of Melbourne | Therapeutic applications |
| EP2653552B1 (de) * | 2010-12-17 | 2016-10-19 | Eisai R&D Management Co., Ltd. | Screeningverfahren als index mit epha4-spaltungsreaktion durch gelatinase |
| US9784751B2 (en) | 2011-04-25 | 2017-10-10 | Eisai R&D Management Co., Ltd. | Method for detecting neurological disease associated with cognitive impairment by measuring EphA4 extracellular domain |
| CA2989993A1 (en) | 2015-09-08 | 2017-03-16 | Eisai R&D Management Co., Ltd. | Anti-epha4 antibody |
| AU2016345063B2 (en) * | 2015-10-27 | 2021-08-05 | The Council Of The Queensland Institute Of Medical Research | A method of treatment and agents useful for same |
| EP3995582B1 (de) | 2019-07-01 | 2026-04-22 | Eisai R&D Management Co., Ltd. | Anti-epha4-antikörper |
| US20240010735A1 (en) * | 2020-12-24 | 2024-01-11 | Eisai R&D Management Co., Ltd. | Therapeutic pharmaceutical composition for amyotrophic lateral sclerosis |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998045708A1 (en) | 1997-04-08 | 1998-10-15 | Sugen, Inc. | Study and treatment of diseases related to specific cellular functions of receptor protein tyrosine kinases |
| US20020068361A1 (en) * | 1997-04-08 | 2002-06-06 | Douglas Clary | Methods of evaluating specific cellular functions of receptor protein tyrosine kinases in a ligand independent manner |
| US20070026409A1 (en) * | 2001-08-14 | 2007-02-01 | The General Hospital Corporation | Nucleic acid and amino acid sequences involved in pain |
| US20060241074A1 (en) * | 2001-08-14 | 2006-10-26 | The General Hospital Corporation | Methods for treatment of pain |
| EP1478772A2 (de) | 2001-08-14 | 2004-11-24 | The General Hospital Corporation | Nukleinsäure- und aminosäuresequenzen im zusammenhang mit schmerzen |
| JP2003169699A (ja) * | 2001-12-10 | 2003-06-17 | Japan Science & Technology Corp | 特異的γプロテアーゼ阻害剤のスクリーニング方法 |
| JP2004000060A (ja) | 2002-05-31 | 2004-01-08 | Otsuka Pharmaceut Co Ltd | アミロイドβ産生に影響を与える化合物のスクリーニング方法 |
| HRP20050461A2 (en) | 2002-11-26 | 2005-08-31 | Pharmacia & Upjohn Company Llc | Soluble notch-based substrates for gamma secretase and methods and compositions for using same |
| EP1693449A4 (de) | 2003-11-10 | 2007-07-25 | Osaka Ind Promotion Org | Zellfreies notch-spaltungsanalyseverfahren und arzneistoff-screening-verfahren |
| JP2007525203A (ja) | 2004-02-27 | 2007-09-06 | オンコセラピー・サイエンス株式会社 | ＰＲＣおよびＰＤＡＣａの治療標的としてのＥｐｈＡ４ |
| EP1662259A1 (de) | 2004-11-25 | 2006-05-31 | Cellzome Ag | Verwendung von Eph Rezeptor-Inhibitoren zur Behandlung von neurodegenerativen Erkrankungen |
| GB0427023D0 (en) * | 2004-12-09 | 2005-01-12 | Merck Sharp & Dohme | Assay method |
| US20070051145A1 (en) * | 2005-09-02 | 2007-03-08 | Ez Trend Technology Co.,Ltd | Electric lock |
| EP1947193A1 (de) | 2007-01-17 | 2008-07-23 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Screening-Verfahren für antidiabetische Zusammensetzungen |
| WO2008150010A1 (ja) | 2007-06-08 | 2008-12-11 | Eisai R & D Management Co., Ltd. | γ-セクレターゼの新規基質EphA4を利用したスクリーニング方法 |
| US20090023158A1 (en) * | 2007-07-13 | 2009-01-22 | Elan Pharmaceuticals, Inc. | Compositions and Methods for Identifying Substrate Specificity of Inhibitors of Gamma Secretase |
| EP2177623A4 (de) * | 2007-07-19 | 2010-12-29 | Eisai R&D Man Co Ltd | SCREENINGVERFAHREN MIT c-MET, EINEM NEUEN SUBSTRAT FÜR GAMMA-SEKRETASE |
| US20090163594A1 (en) * | 2007-10-31 | 2009-06-25 | Elan Pharmaceuticals, Inc. | Triple Assay System for Identifying Substrate Selectivity of Gamma Secretase Inhibitors |
| EP2223999B1 (de) * | 2007-11-30 | 2017-10-18 | Eisai R&D Management Co., Ltd. | Epha4-polypeptid mit neuartiger aktivität und verwendung davon |
| US20100113415A1 (en) * | 2008-05-29 | 2010-05-06 | Rajapakse Hemaka A | Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer |
-
2008
- 2008-06-09 WO PCT/JP2008/060567 patent/WO2008150010A1/ja not_active Ceased
- 2008-06-09 US US12/135,307 patent/US7910324B2/en active Active
- 2008-06-09 AT AT08765357T patent/ATE546543T1/de active
- 2008-06-09 EP EP08765357A patent/EP2166110B1/de active Active
- 2008-06-09 JP JP2009517923A patent/JP5511377B2/ja active Active
-
2011
- 2011-01-19 US US13/009,127 patent/US8137926B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20090142788A1 (en) | 2009-06-04 |
| US8137926B2 (en) | 2012-03-20 |
| EP2166110A4 (de) | 2010-07-28 |
| WO2008150010A1 (ja) | 2008-12-11 |
| EP2166110A1 (de) | 2010-03-24 |
| JPWO2008150010A1 (ja) | 2010-08-26 |
| JP5511377B2 (ja) | 2014-06-04 |
| US7910324B2 (en) | 2011-03-22 |
| EP2166110B1 (de) | 2012-02-22 |
| US20110111444A1 (en) | 2011-05-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2166110A4 (de) | Screening-verfahren mit verwendung des neuen substrats epha4 für gamma-sekretase | |
| ATE514755T1 (de) | Fluoreszenzfarbstoffe zur verwendung bei der glukoseerfassung | |
| WO2009073201A3 (en) | Alternate labeling strategies for single molecule sequencing | |
| ATE541054T1 (de) | Bio-barcode erkennung für zielmoleküle | |
| EP1679508A4 (de) | Biosensor und verfahren zu dessen herstellung | |
| ATE535612T1 (de) | Toxizitätsscreeningverfahren | |
| ATE526333T1 (de) | Reagentien zum nachweis von hypochloriger säure | |
| ATE525482T1 (de) | Nanoreporter und verfahren zu deren herstellung und verwendung | |
| ATE428929T1 (de) | Reagens, ausstattung und verfahren zur probenanalyse | |
| ATE431854T1 (de) | Auf bio-barcodes beruhender nachweis von zielanalyten | |
| DE602007013524D1 (de) | Erkennung und vorhersage von frühgeburten | |
| WO2007045865A3 (en) | Methods and biomarkers for diagnosing and monitoring psychotic disorders such as schizophrenia | |
| WO2009011426A1 (ja) | γ-セクレターゼの新規基質c-Metを利用したスクリーニング方法 | |
| DK2118666T3 (da) | Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve | |
| EA200701742A1 (ru) | Способы получения сиропа | |
| ATE504836T1 (de) | Verfahren zur identifizierung von trpv2- modulatoren | |
| WO2009064006A1 (ja) | γ-セクレターゼの新規基質EphA7を利用したスクリーニング方法 | |
| WO2008104638A3 (en) | Improved homogeneous luminescence bioassay | |
| MX2007012486A (es) | Ensayos de investigacion sobre estilbazio. | |
| WO2009017234A1 (ja) | γ-セクレターゼの新規基質c-Retを利用したスクリーニング方法 | |
| ATE525462T1 (de) | Proteomanalyseverfahren für phosphoryliertes protein | |
| Lee et al. | How do elevated CO2 and nitrogen addition affect functional microbial community involved in greenhouse gas flux in salt marsh system | |
| GB2437545B (en) | Dextrin-containing reagents for detecting and quantifying proteins | |
| DK1613772T3 (da) | Fremgangsmåde til bestemmelse af tilstanden af jord | |
| DE602005013430D1 (de) | Verwendung von asc als marker für kolorektalkarzinome |